Heidelberg, Baden-Wurttemberg, Germany Heidelberg Innovation is the famous VC, which was founded in 1997. The leading representative office of defined VC is situated in the Heidelberg. The venture was found in Europe in Germany.
This organization was formed by Ulrich Abshagen.
Among the most popular portfolio startups of the fund, we may highlight Vasopharm, Santhera Pharmaceuticals, Pelikan Technologies. For fund there is a match between the location of its establishment and the land of its numerous investments - Germany. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Health Diagnostics.
This Heidelberg Innovation works on 15 percentage points more the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2012. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 2 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2005.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Heidelberg Innovation, startups are often financed by Bayern Kapital GmbH, High-Tech Gru00fcnderfonds, Wellington Partners. The meaningful sponsors for the fund in investment in the same round are Oxford Bioscience Partners, NGN Capital, Mannheim Holdings. In the next rounds fund is usually obtained by HBM Healthcare Investments AG, Bayern Kapital GmbH, Wellington Partners.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 33 Capital | - |
| Biltmore Ventures | Arizona, Phoenix, United States |
| Centerbeam, Inc. | California, Sunnyvale, United States |
| Engelhardt Kaupp Kiefer | Baden-Wurttemberg, Germany, Stuttgart |
| Essex Flagship Investors Group | Boston, Massachusetts, United States |
| Fayerweather Fund | Cambridge, Massachusetts, United States |
| Investcorp | Bahrain, Capital Governorate, Manama |
| JPMorgan Fleming Asset Management | - |
| La Chapelle | China, Shanghai |
| Seine Limited | China, Hong Kong, Hong Kong Island |
| Seyen Capital | Chicago, Illinois, United States |
| Shanghai Ashe Investment Management | China, Shanghai |
| Signature Bank | New York, New York, United States |
| Silver Chalice Ventures | Chicago, Illinois, United States |
| Tokyo Tatemono | Japan, Tokyo |
| Wande Touzi | China, Shanghai |
| Zions Bancorporation | Salt Lake City, United States, Utah |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
MTM Laboratories | $28M | 10 Oct 2006 | Baden-Württemberg | ||
Vasopharm | $11M | 30 Jan 2006 | Bavaria | ||
Santhera Pharmaceuticals | $18M | 20 Dec 2005 | Basel-Country, Switzerland | ||
Alantos Pharmaceuticals | $20M | 10 Mar 2005 | Cambridge, Massachusetts, United States | ||
Santhera Pharmaceuticals | $16M | 17 Dec 2004 | Basel-Country, Switzerland | ||
Pelikan Technologies | $14M | 16 Dec 2002 | Palo Alto, California, United States | ||
CellZome | $31M | 01 Mar 2001 | Germany, Heidelberg | ||
MTM Laboratories | $1M | 30 Aug 1999 | Baden-Württemberg |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
MTM Laboratories | $28M | 10 Oct 2006 | Baden-Württemberg | ||
Vasopharm | $11M | 30 Jan 2006 | Bavaria | ||
Santhera Pharmaceuticals | $18M | 20 Dec 2005 | Basel-Country, Switzerland | ||
Alantos Pharmaceuticals | $20M | 10 Mar 2005 | Cambridge, Massachusetts, United States | ||
Santhera Pharmaceuticals | $16M | 17 Dec 2004 | Basel-Country, Switzerland | ||
Pelikan Technologies | $14M | 16 Dec 2002 | Palo Alto, California, United States | ||
CellZome | $31M | 01 Mar 2001 | Germany, Heidelberg | ||
MTM Laboratories | $1M | 30 Aug 1999 | Baden-Württemberg |
